MARKER THERAPEUTICS, INC. Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value
MARKER THERAPEUTICS, INC. (MRKR) had Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value of $10.00 million as of 2015-09-30, per its 10-Q/A filed 2016-04-14.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue · last filed 2016-04-14
- 2015-09-30: Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value $10.00M.
- 2015-06-30: Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value $10.00M.
- 2014-12-31: Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value $10.00M.
| Period end | Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value |
|---|---|
| 2015-09-30 | $10.00M 10-Q/A · filed 2016-04-14 |
| 2015-06-30 | $10.00M 10-Q/A · filed 2016-04-14 |
| 2014-12-31 | $10.00M 10-Q/A · filed 2016-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |